|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 10/31/19 Idexx Laboratories Inc/DE 10-Q 9/30/19 96:10M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 1.59M
2: EX-31.1 Certification -- §302 - SOA'02 HTML 34K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 34K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 29K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 29K
92: R1 Cover Page HTML 80K
37: R2 Condensed Consolidated Balance Sheets HTML 141K
25: R3 Condensed Consolidated Balance Sheets HTML 43K
(Parenthetical)
61: R4 Condensed Consolidated Statements of Income HTML 99K
91: R5 Condensed Consolidated Statements of Comprehensive HTML 68K
Income
36: R6 Condensed Consolidated Statements of Comprehensive HTML 37K
Income (Parenthetical)
24: R7 Condensed Consolidated Statements of Stockholders' HTML 103K
Equity (Deficit)
59: R8 Condensed Consolidated Statements of Stockholders' HTML 30K
Equity (Deficit) (Parenthetical)
94: R9 Condensed Consolidated Statements of Cash Flows HTML 118K
18: R10 Basis of Presentation and Principles of HTML 34K
Consolidation
47: R11 Accounting Policies HTML 71K
82: R12 Revenue Recognition HTML 149K
71: R13 Acquisitions HTML 31K
19: R14 Share-Based Compensation HTML 43K
48: R15 Inventories HTML 37K
84: R16 Property and Equipment, Net HTML 29K
72: R17 Leases HTML 50K
17: R18 Other Current and Long-Term Assets HTML 55K
49: R19 Accrued Liabilities HTML 47K
85: R20 Debt HTML 31K
53: R21 Repurchases Of Common Stock HTML 67K
22: R22 Income Taxes HTML 31K
32: R23 Accumulated Other Comprehensive Income HTML 103K
86: R24 Earnings Per Share HTML 58K
54: R25 Commitments, Contingencies and Guarantees HTML 32K
23: R26 Segment Reporting HTML 196K
33: R27 Fair Value Measurements HTML 111K
87: R28 Hedging Instruments HTML 114K
52: R29 Accounting Policies (Policies) HTML 107K
69: R30 Accounting Policies (Tables) HTML 65K
81: R31 Revenue Recognition (Tables) HTML 90K
51: R32 Share-Based Compensation (Tables) HTML 39K
21: R33 Inventories (Tables) HTML 38K
68: R34 Leases (Tables) HTML 46K
80: R35 Other Current and Long-Term Assets (Tables) HTML 57K
50: R36 Accrued Liabilities (Tables) HTML 48K
20: R37 Repurchases of Common Stock (Tables) HTML 66K
70: R38 Accumulated Other Comprehensive Income (Tables) HTML 105K
79: R39 Earnings Per Share (Tables) HTML 59K
60: R40 Segment Reporting (Tables) HTML 194K
96: R41 Fair Value Measurements (Tables) HTML 100K
35: R42 Hedging Instruments (Tables) HTML 99K
27: R43 Accounting Policies (Details) HTML 71K
58: R44 Revenue Recognition (General Narrative) (Details) HTML 31K
95: R45 Revenue Recognition (Lease Revenue) (Details) HTML 28K
34: R46 Revenue Recognition (Extended Warranties and HTML 43K
Post-Contract Support) (Details)
26: R47 Revenue Recognition (SaaS Subscriptions) (Details) HTML 29K
62: R48 Revenue Recognition (Up-Front Customer Loyalty HTML 37K
Programs) (Details)
90: R49 Revenue Recognition (Volume Commitment Programs) HTML 33K
(Details)
75: R50 Revenue Recognition (Instrument Rebate Programs) HTML 33K
(Details)
66: R51 Revenue Recognition (Reagent Rental Programs) HTML 38K
(Details)
11: R52 Revenue Recognition (Disaggregation of Revenue by HTML 56K
Major Product and Service Categories) (Details)
41: R53 Revenue Recognition (Disaggregation of Revenue by HTML 41K
Principal Geographic Area, Based on Customers'
Domiciles) (Details)
76: R54 Revenue Recognition (Costs to Obtain a Contract) HTML 41K
(Details)
67: R55 Revenue Recognition (Remaining Performance HTML 70K
Obligation) (Details)
12: R56 Acquisitions (Details) HTML 52K
42: R57 Share-Based Compensation (Narrative) (Details) HTML 37K
77: R58 Share-Based Compensation (Assumptions Used) HTML 38K
(Details)
65: R59 Inventories (Details) HTML 38K
29: R60 Property and Equipment, Net (Details) HTML 30K
38: R61 Leases (Maturities of Operating Lease Liabilities) HTML 56K
(Details)
88: R62 Leases (Supplemental Cash Flow Information) HTML 30K
(Details)
56: R63 Leases (Narrative) (Details) HTML 27K
30: R64 Leases (Previous Lease Accounting Minimum Annual HTML 44K
Rental Payments) (Details)
39: R65 Other Current and Long-Term Assets (Schedule Of HTML 44K
Other Current Assets) (Details)
89: R66 Other Current and Long-Term Assets (Schedule Of HTML 46K
Other Long-term Assets) (Details)
57: R67 Accrued Liabilities (Schedule Of Accrued HTML 43K
Liabilities) (Details)
28: R68 Accrued Liabilities (Schedule Of Other Long-term HTML 34K
Liabilities) (Details)
40: R69 Debt (Details) HTML 44K
45: R70 Repurchases of Common Stock (Details) HTML 47K
14: R71 Income Taxes (Details) HTML 29K
64: R72 Accumulated Other Comprehensive Income (Schedule HTML 53K
Of AOCI) (Details)
74: R73 Accumulated Other Comprehensive Income (Schedule HTML 45K
of Reclassifications out of AOCI) (Details)
44: R74 Earnings Per Share (Schedule Of Reconciliation Of HTML 38K
Shares Outstanding For Basic And Diluted Earnings
Per Share) (Details)
13: R75 Earnings Per Share (Schedule Of Number Of HTML 31K
Anti-Dilutive Stock Options) (Details)
63: R76 Segment Reporting (Details) HTML 79K
73: R77 Fair Value Measurements (Narrative) (Details) HTML 32K
43: R78 Fair Value Measurements (Schedule of Assets and HTML 73K
Liabilities) (Details)
16: R79 Hedging Instruments (Narrative) (Details) HTML 63K
46: R80 Hedging Instruments (Derivatives Designated In HTML 37K
Cash Flow Hedging Relationships) (Details)
15: R81 Hedging Instruments (Schedule Of Fair Values And HTML 67K
Balance Sheet Classifications Of Derivatives
Designated As Hedging Instruments) (Details)
93: XML IDEA XML File -- Filing Summary XML 181K
55: XML XBRL Instance -- idxx2019q310-q_htm XML 2.90M
31: EXCEL IDEA Workbook of Financial Reports XLSX 97K
7: EX-101.CAL XBRL Calculations -- idxx-20190930_cal XML 264K
8: EX-101.DEF XBRL Definitions -- idxx-20190930_def XML 536K
9: EX-101.LAB XBRL Labels -- idxx-20190930_lab XML 1.48M
10: EX-101.PRE XBRL Presentations -- idxx-20190930_pre XML 918K
6: EX-101.SCH XBRL Schema -- idxx-20190930 XSD 158K
78: JSON XBRL Instance as JSON Data -- MetaLinks 355± 521K
83: ZIP XBRL Zipped Folder -- 0000874716-19-000036-xbrl Zip 317K
| Exhibit |
1) | I
have reviewed this report on Form 10-Q for the quarter ended September 30, 2019 of IDEXX Laboratories, Inc.; |
2) | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3) | Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4) | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report, based on such evaluation;
and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;
and |
5) | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date:
October 31, 2019 | |
| |
| President and Chief Executive Officer |
| (Principal Executive Officer) |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 10/31/19 | 4, 8-K | ||
| For Period end: | 9/30/19 | |||
| List all Filings | ||||